Adult Immunization Allergy & Immunology Cardiology Dermatology Endocrinology Gastroenterology Infectious Disease Men’s Health Nephrology Neurology Pain Management Pediatric Immunization Pediatrics Psychiatry Pulmonology Rheumatology Screening Women’s Health

Billing and Collections Career Planning Coding and Documentation Concierge Medicine Cybersecurity EHRs Investing Patient Relations Personal Finance Practice Management Remote Patient Monitoring Staffing Technology Telehealth Value-based Care

VMS and Menopause T1D: Paving the Path to Prevention Adult Immunization Center Dermatology Hot Topics

Briana Contreras

home / authors / briana-contreras

Articles

FDA's First Draft Guidance on Clinical Trials with Psychedelic Drugs Now Available for Comment ©agsandrew/AdobeStock

FDA's First Draft Guidance on Clinical Trials with Psychedelic Drugs Now Available for Comment

Briana Contreras

The FDA's recommendations serve to inform potential research sponsors on development protocols for psychedelics and to solicit comment from industry.

Terms and Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.